Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers (Q83716874)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437412%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437412%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Hiddo J Lambers Heerspink

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437412%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Frank A Holtkamp

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437412%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Hans-Henrik Parving

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437412%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Gerjan J Navis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437412%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Julia B Lewis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437412%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Eberhard Ritz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437412%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Pieter A de Graeff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437412%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Dick de Zeeuw

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437412%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

English

0 references

publication date

21 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437412%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437412%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437412%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

330-337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437412%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437412%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2012.74

26 January 2020

exact match

0 references

cites work

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Effects of salt supplementation on the albuminuric response to telmisartan with or without hydrochlorothiazide therapy in hypertensive patients with type 2 diabetes are modulated by habitual dietary salt intake.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Dietary salt intake and mortality in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Standards of medical care in diabetes--2011.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Associations of diet with albuminuria and kidney function decline

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Fatal and Nonfatal Outcomes, Incidence of Hypertension, and Blood Pressure Changes in Relation to Urinary Sodium Excretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Sodium intake, ACE inhibition, and progression to ESRD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Altered dietary salt intake for preventing and treating diabetic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

A low-sodium diet potentiates the effects of losartan in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Benefits of dietary sodium restriction in the management of chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

High Dietary Sodium Blunts Effects of Angiotensin-converting Enzyme Inhibition on Vascular Angiotensin I–to–Angiotensin II Conversion in Rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021

Diabetic bladder dysfunction: current translational knowledge

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.74

7 January 2021